The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 361:1500-1501 October 8, 2009 Number 15
NextNext

Micromanaging Cancer
Judy Lieberman, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Ji, J.
-PubMed Citation
The discovery of RNA interference triggered a "silent" revolution that overturned our understanding of how gene expression is regulated.1 The previous model was that gene expression was activated during transcription, the process of copying the DNA sequence into RNA, when transcription factor proteins bind to promoter sequences in DNA upstream of the gene's coding sequence. Now it is clear that an additional important mechanism of gene regulation occurs at the next stage of translating the messenger RNA (mRNA) into protein. Small, noncoding RNAs that have a stem loop structure, called microRNAs, regulate translation by binding to partially complementary sequences of . . . [Full Text of this Article]


Source Information

From the Immune Disease Institute and the Program in Cellular and Molecular Medicine at Children's Hospital Boston and the Department of Pediatrics, Harvard Medical School, Boston.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.